About Us

Transforming biomedical data into better outcomes for everyone

“I am driven by the difference we can make – and are making – for patients, for caregivers and for innovators pushing the boundaries of what’s possible in medicine.”

Friedrich von Bohlen, CEO

HISTORY

Since 2004, Molecular Health has stood for transforming big data into precise, actionable decisions for all stakeholders in healthcare.

Our cloud-based Dataome™ technology platform analyzes the molecular and clinical data of individual patients against the world’s medical, biological, and pharmacological knowledge, to drive more precise diagnostic, therapeutic, and drug safety decisions.

Our products are used across the healthcare sector, as more precise ways of practicing medicine impact the treatment of patients and the development of effective drugs, requiring ever more complex levels of data interpretation.

The company is financed by Dievini Hopp BioTech, an investment vehicle of former SAP CEO and founder Dietmar Hopp.

Meet our Board of Directors

Christof Hettich

Lawyer and partner at RITTERSHAUS Rechtsanwälte in Mannheim/Frankfurt/Munich. Also the co-founder and managing director of dievini Hopp BioTech holding GmbH & Co. KG.

Prof. Christof Hettich, PhD

Lawyer and partner at RITTERSHAUS Rechtsanwälte

Mathias Hothum

Owner of HMM-Consulting, received a degree in Economics from the University of Mannheim. He completed his doctoral studies at the University of Magdeburg.

Mathias Hothum, PhD

Owner of HMM-Consulting

Alexander Schuth

Co-founder and COO of Denali Therapeutics, a San Francisco based biotech company dedicated to the discovery and development of therapies for neurodegenerative diseases. He holds an M.B.A. from the Wharton School and an M.D. from the Charité Medical School at the Humboldt University.

Alexander Schuth, MD

Co-founder and COO of Denali Therapeutics

Meet the Management Team

Friedrich von Bohlen, PhD

Chief Executive Officer

Stephan Brock, PhD

Chief Technology Officer

Rudolf Caspary, PhD

Chief Information Officer

Dr. Christian Meisel

Chief Medical Officer

David Jackson, PhD

Chief Innovation Officer

Blanca Baez

SVP, Global Head of Pharma & Biotech

Stephan Hettich, Dipl.-Kfm.

SVP, Head of Business Development, Sales and Marketing EMEA/APAC

Niels Bojunga, PhD

SVP Quality Management

Thorsten Vogt

Head of HR

Michael Ghaffar, LL.M.

General Counsel

Torsten Bürgermeister

SVP Finance & Administration

Moving healthcare forward

We work with some of the world’s most renowned healthcare organizations. And hopefully you, too, one day soon.
  • Agena Bioscience

Quality counts — and we’ve proven ours

Our quality processes have achieved international certifications.

Investors

Molecular Health is financed by dievini Hopp BioTech, an investment vehicle of former SAP CEO and founder Dietmar Hopp.

dievini is an active investor in life and health sciences companies. The company is dedicated to advancing innovative therapeutic and diagnostic technologies to establish novel treatment regimens for life-threatening diseases. Established by Dietmar Hopp, founder and former Chairman and CEO of SAP, the company maintains deep roots in the health and technology sectors and is led by a team with an extensive track record of building scalable, sustainable life science and health technology companies.

Dievini - advisors in health sciences